Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Zydus Lifesciences Limited
Press Release May 04 2024
Business
May 4 2024
3 min read

Press Release May 04 2024

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 04, 2024, titled "Sentynl Therapeutics announces global acquisition of Zokinvy�� (Lonafarnib) for treatment of Hutchinson-Gilford Progeria Syndrome from Eiger Biopharmaceuticals".

View Attachment